NDC 0002-4479

Olumiant

Baricitinib

Olumiant is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Baricitinib.

• Product ID: 0002-4479_15ef688b-408f-4678-96b6-20068241d6db
• NDC: 0002-4479
• Product Type: Human Prescription Drug
• Proprietary Name: Olumiant
• Generic Name: Baricitinib
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2022-05-10
• Marketing Category: NDA /
• Application Number: NDA207924
• Labeler Name: Eli Lilly and Company
• Substance Name: BARICITINIB
• Active Ingredient Strength: 4 mg/1
• Pharm Classes: Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0002-4479-30

30 TABLET, FILM COATED in 1 BOTTLE (0002-4479-30)

• Marketing Start Date: 2022-05-10
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Olumiant" or generic name "Baricitinib"

NDC	Brand Name	Generic Name
0002-4182	Olumiant	baricitinib
0002-4479	Olumiant	baricitinib
0002-4732	Olumiant	baricitinib
0002-6885	Baricitinib	baricitinib